期刊论文详细信息
Frontiers in Cardiovascular Medicine | |
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension | |
Feifei Lv1  Lanjuan Li2  Qiaoling Pan2  Jinfeng Yang2  Hongcui Cao2  Xinyu Sheng2  Xiaowei Shi2  Jiong Yu2  Jing Ma3  Jian Wu4  | |
[1] Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China;State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China;Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;Department of Laboratory Medicine, The First People's Hospital of Yancheng City, Yancheng, China; | |
关键词: angiotensin-converting enzyme inhibitors; angiotensin receptor blockers; COVID-19; hypertension; SARS-CoV-2; | |
DOI : 10.3389/fcvm.2021.577398 | |
来源: Frontiers | |